Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline B Pantazis

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Addiction Biology|March 22, 2019
Lateral septum inhibition reduces motivation for cocaine: Reversal by diazepamCaroline B Pantazis, Gary Aston-Jones
Brain Research|September 19, 2019
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanilAida Mohammadkhani, Morgan H James, Caroline B Pantazis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 22, 2019
The role of orexin-1 receptor signaling in demand for the opioid fentanylJennifer E Fragale, Caroline B Pantazis, Morgan H James, et al.
Addiction Biology|July 13, 2019
The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demandCaroline B Pantazis, Morgan H James, Brandon S Bentzley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2021
Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaineCaroline B Pantazis, Morgan H James, Shayna O'Connor, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2019
Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid RemifentanilAida Mohammadkhani, Jennifer E Fragale, Caroline B Pantazis, et al.
Science Advances|April 8, 2021
Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addictionCaroline B Pantazis, Luis A Gonzalez, Brendan J Tunstall, et al.
International Review of Neurobiology|March 2, 2021
Drug addiction co-morbidity with alcohol: Neurobiological insightsM Adrienne McGinn, Caroline B Pantazis, Brendan J Tunstall, et al.
Medrxiv : the Preprint Server for Health Sciences|December 31, 2025
Exploring MAPT-containing H1 and H2 haplotypes in Parkinson's disease across diverse populationsPaula Reyes-Pérez, Jia Wei Hor, Tzi Shin Toh, et al.
NPJ Parkinson'S Disease|June 24, 2026
Exploring MAPT-containing H1 and H2 haplotypes in Parkinson's disease across diverse populationsPaula Reyes-Pérez, Jia Wei Hor, Tzi Shin Toh, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Addiction Biology|March 22, 2019
Lateral septum inhibition reduces motivation for cocaine: Reversal by diazepamCaroline B Pantazis, Gary Aston-Jones
Brain Research|September 19, 2019
Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanilAida Mohammadkhani, Morgan H James, Caroline B Pantazis, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 22, 2019
The role of orexin-1 receptor signaling in demand for the opioid fentanylJennifer E Fragale, Caroline B Pantazis, Morgan H James, et al.
Addiction Biology|July 13, 2019
The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demandCaroline B Pantazis, Morgan H James, Brandon S Bentzley, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 12, 2021
Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaineCaroline B Pantazis, Morgan H James, Shayna O'Connor, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2019
Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid RemifentanilAida Mohammadkhani, Jennifer E Fragale, Caroline B Pantazis, et al.
Science Advances|April 8, 2021
Cues conditioned to withdrawal and negative reinforcement: Neglected but key motivational elements driving opioid addictionCaroline B Pantazis, Luis A Gonzalez, Brendan J Tunstall, et al.
International Review of Neurobiology|March 2, 2021
Drug addiction co-morbidity with alcohol: Neurobiological insightsM Adrienne McGinn, Caroline B Pantazis, Brendan J Tunstall, et al.
Medrxiv : the Preprint Server for Health Sciences|December 31, 2025
Exploring MAPT-containing H1 and H2 haplotypes in Parkinson's disease across diverse populationsPaula Reyes-Pérez, Jia Wei Hor, Tzi Shin Toh, et al.
NPJ Parkinson'S Disease|June 24, 2026
Exploring MAPT-containing H1 and H2 haplotypes in Parkinson's disease across diverse populationsPaula Reyes-Pérez, Jia Wei Hor, Tzi Shin Toh, et al.
Pageof 3